🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆
Updated 04 Jul 2026 · HPRA open data

GE Healthcare AS — Licensed Medicines

19 medicines held by GE Healthcare AS on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 19 products held by GE Healthcare AS
MedicineActive substanceLicence holderStatus
Clariscan 279.32 mg/ml solution for injection
PA0735/011/001
 Gadoteric acid GE Healthcare AS Marketed
Clariscan 279.32 mg/ml solution for injection in pre-filled syringe
PA0735/011/002
 Gadoteric acid GE Healthcare AS Marketed
MYOVIEW 230 micrograms kit for radiopharmaceutical preparation
PA0735/012/001
 Tetrofosmin GE Healthcare AS Not marketed
Omnipaque 140 mg I/ml Solution for Injection (Glass)
PA0735/006/001
 Iohexol GE Healthcare AS Not marketed
Omnipaque 180 mg I/ml Solution for Injection (Glass)
PA0735/006/002
 Iohexol GE Healthcare AS Marketed
Omnipaque 240 mg I/ml Solution for Injection (Glass)
PA0735/006/004
 Iohexol GE Healthcare AS Marketed
Omnipaque 240 mg I/ml Solution for Injection (Polypropylene)
PA0735/006/023
 Iohexol GE Healthcare AS Marketed
Omnipaque 300 mg I/ml Solution for Injection (Glass)
PA0735/006/008
 Iohexol GE Healthcare AS Marketed
Omnipaque 300 mg I/ml Solution for Injection (Polypropylene)
PA0735/006/018
 Iohexol GE Healthcare AS Marketed
Omnipaque 350 mg I/ml Solution for Injection (Glass)
PA0735/006/013
 Iohexol GE Healthcare AS Not marketed
Omnipaque 350 mg I/ml Solution for Injection (Polypropylene)
PA0735/006/020
 Iohexol GE Healthcare AS Marketed
OPTISON 0.19 mg/ml dispersion for injection
EU/1/98/065/001
 Perflutren, Human albumin microspheres GE Healthcare AS —
OPTISON 0.19 mg/ml dispersion for injection
EU/1/98/065/002
 Perflutren, Human albumin microspheres GE Healthcare AS —
Rapiscan 400 microgram solution for injection
EU/1/10/643/001
 Regadenoson GE Healthcare AS —
VISIPAQUE 270 mg I/ml Solution for Injection, glass container
PA0735/009/003
 Iodixanol GE Healthcare AS Marketed
VISIPAQUE 270 mg I/ml Solution for Injection, polypropylene container
PA0735/009/012
 Iodixanol GE Healthcare AS Marketed
VISIPAQUE 320 mg I/ml Solution for Injection, glass container
PA0735/009/007
 Iodixanol GE Healthcare AS Marketed
Visipaque 320 mg I/ml Solution for Injection, polypropylene container
PA0735/009/013
 Iodixanol GE Healthcare AS Marketed
VIZAMYL 400 MBq/mL solution for injection
EU/1/14/941/001-002
 Flutemetamol (18F) GE Healthcare AS —
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 20 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.